“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Kevin A. Lobo, Chair and Chief Executive Officer, ...

Before Stryker, Wells had 17 years of senior accounting and financial management experience, holding finance leadership roles at Dialight Corporation and Johnson & Johnson. He graduated from Bucknell ...

Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...

Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York ...

Stryker beat estimated earnings by 4.0%, reporting an EPS of $4.01 versus an estimate of $3.87. Revenue was up $621.00 million from the same period last year.

Stryker plans to sell its U.S. spinal implants business, the company said Jan. 28. The U.S. spine segment will be sold to investment firm Viscogliosi Brothers, and that group will create VB Spine, ...

Stryker's CFO Glenn Boehnlein is retiring, and Preston Wells will succeed him as vice president and CFO, according to a Jan. 28 news release.

Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal ...

KBR will be responsible for operating a Diplomatic Support Hospital and four clinics to support more than 4,000 personnel.